Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Can J Cardiol. 2021 Feb 19;37(5):756–765. doi: 10.1016/j.cjca.2021.01.027

Figure 1.

Figure 1.

Overview of pathophysiologies and epiphenomema associated with obstructive sleep apnea which increase cardiovascular (CV) risk (dark text) along with potential adjunct treatments and therapeutic targets to reduce CV risk (red text). OB, obesity; HTN, hypertension; T2DM, type 2 diabetes mellitus; HNS; hypoglossal nerve stimulators; MAD, mandibular advancement devices.